Showing 251-260 of 2132 results for "".
Chronic Pain: Opioid Tapering
https://practicalneurology.com/diseases-diagnoses/headache-pain/chronic-pain-opioid-tapering/31772/A pragmatic approach may help optimize opioid tapering in adults with chronic pain.Incorporating FcRn Inhibitors Into Clinical Practice in Chronic Inflammatory Demyelinating Polyneuropathy
https://practicalneurology.com/programs/cme/incorporating-fcrn-inhibitors-into-clinical-practice-in-chronic-inflammatory-demyelinating-polyneuropathy/27135/Tune in to learn more about how to incorporate FcRn inhibitors into clinical practice for inflammatory demyelinating polyneuropathy (CIDP).The First Seizure
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/the-first-seizure/31585/Seizures need to be distinguished from other common differential diagnoses, and seizure type must be determined because it dictates management and counseling.Migraine Preventive Therapies in Development
https://practicalneurology.com/diseases-diagnoses/headache-pain/migraine-preventive-therapies-in-development/31512/The field of headache medicine is full of promise with more migraine-specific preventive therapies in development.Multiple Sclerosis in the Black Population of the United States
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-in-the-black-population-of-the-united-states/31756/Black people with multiple sclerosis are affected by frequent relapses, early disability accrual, and rapid disease progression.Inflammatory Myopathies
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/inflammatory-myopathies/31812/Clinicopathologic classfication can aid understanding and guide treatment.Improving Outcomes Earlier in Generalized Myasthenia Gravis: Roadmap for Incorporating Targeted Therapies Into Clinical Practice
https://practicalneurology.com/programs/cme/improving-outcomes-earlier-in-generalized-myasthenia-gravis-roadmap-for-incorporating-targeted-therapies-into-clinical-practice/29145/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Neuropsychologic Assessment for Neurodegeneration
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/neuropsychologic-assessment-for-neurodegeneration/31532/What is the value of neuropsychologic assessment in neurodegenerative diseases?Movement Disorders Moment: Incorporating Lifestyle Medicine Into Parkinson Disease Care—Evidence and Guidance for Clinical Practice
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-incorporating-lifestyle-medicine-into-parkinson-disease-care-evidence-and-guidance-for-clinical-practice/32196/Lifestyle medicine strategies play an important role in managing Parkinson disease and empowering patients and their care partners.COVID-19 & Stroke
https://practicalneurology.com/diseases-diagnoses/stroke/covid-19-stroke/31740/COVID-19 has brought significant changes in stroke presentations, systems of care, and resource availability.